Dem Sen. Bob Casey still airing ‘disrespectful’ ad featuring Jamal Khashoggi despite widow’s pleas
The TV ad was still airing on networks in Philadelphia, Harrisburg and Scranton as of Thursday, upsetting Hanan Elatr ...
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
With TV Drug Ads, What You See Is Not Necessarily What You Get
The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...
FDA Expands Use of Breast Cancer Drug Kisqali
Women with early-stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the ...
Cure Today4d
Kisqali Plus Aromatase Inhibitor Shows Benefits in HR+/HER2- Breast Cancer
Findings from the NATALEE trial show that the combination of Kisqali and an aromatase inhibitor resulted in disease-free ...
MarketWatch6d
Novartis' Kisqali Reduces Breast Cancer Recurrence by Nearly One-Third, Trials Show
Novartis said that its Kisqali drug reduces the risk of breast cancer recurrence by nearly one-third, in updated analysis from Phase 3 trials. The Swiss pharmaceutical company said Monday that its ...
Monthly Prescribing Reference4d
Kisqali Approved for HR-Positive, HER2-Negative Early Breast Cancer
“We continue to transform cancer care with Kisqali, building on its established profile in the metastatic setting and now helping a wide range of people as they strive to stay cancer-free ...
Business Insider4d
Novartis AG: Hold Rating Justified Amid Kisqali’s Market Potential and FDA Approval
Eric Le Berrigaud’s rating is based on the comprehensive analysis of Novartis AG’s recent developments and market potential for its breast cancer treatment, Kisqali. The FDA’s approval of ...
NBC New York5d
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
NBC News5d
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.